Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03020225
Other study ID # BenGurionU
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date December 2016
Est. completion date July 2017

Study information

Verified date January 2022
Source Ben-Gurion University of the Negev
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The investigators aim to test the protein bioavailability of new specific developed strain of duckweed [Wolffia globose, Mankai] , an aquatic plant, which might serve as a protein source and contains all the 9 essential and the 6 conditional amino acids. The investigators will randomize 36 participants to consume equivalent protein (30gr) content of 3 whole foods items: 1. White cheese (animal protein source, as a reference); 2. Green peas, intact, cooked (plant protein source); 3. Wolffia globosa (Mankai), intact, cooked (plant protein source). The foods will be consumed in the morning, following 12h fasting. The foods will be provided with 250ml mineral water and the blood follow-up frame will be for 3 hours. Primary outcome: Blood amino acid profile.


Description:

The investigators aim to test the protein bioavailability of new specific developed strain of duckweed [Wolffia globose, Mankai], an aquatic plant, which might serve as a protein source and contains all the 9 essential and the 6 conditional amino acids. "Mankai" [(Generally recognized as safe (GRAS)] is a cultivated strain of Wolffia globosa, which is an aquatic plant, part of the family of plants known commonly as duckweeds. Duckweeds are very simple flowering aquatic plants which float on or just beneath the surface of still or slow-moving bodies of water. There is a long history of the use of Wolffia species, in particular Wolffia Globosa, as food, especially in Southeast Asia: Burma, Laos and northern Thailand, where it has been used as a vegetable for many generations. There are numerous ways of W. globosa consumption and a variety of recipes, using it either as a main ingredient (such as Wolffia crisps or "kaeng pum" - a popular vegetable dish in northeastern Thailand) or incorporating it in other foods (e.g. Wolffia-meat ball, fermented Wolffia-meat sausage, Wolffia rice noodle, Wolffia cookies, Wolffia bread, and various soups and salads). Along with its long history as a food source in Southeast Asia, it is recognized as an edible vegetable for humans in several databases, including the United States Department of Agriculture (USDA 2014) GRIN database and a database dedicated to tropical species. The nutritional composition of Mankai has been determined and found to be high in protein, containing all the essential and conditionally essential amino acids, dietary fibers and several vitamins and minerals. In a recent safety study, which aimed to test the safety of Mankai administration within and 3 times of the amount approved in the GRAS, 4 groups of female SD rats were orally administered for 4 consecutive days a daily dose of Mankai at three dose levels of 1700, 2500 and 3400mg/kg of Mankai, equivalent to 20, 40 and 60 gr/day human dose, respectively. Clinical (e.g body weight, food intake, morbidity/mortality, toxic signs), pathological (post mortem gross pathology examination) and long list of blood biochemical indicators (e.g liver status biomarkers, stress indicators, minerals) did not show any adverse effects. The results indicate that repeated four day Mankai administration did not cause adverse effects. Unexpectedly, high doses even suggested beneficial results with anti-glycemic effects. Mankai was found to have a high digestibility profile (89%) according to Protein digestibility-corrected amino acid score (PDCAAS) Eurofins tests. However, its human nutrient bioavailability has not been examined yet. For the proposed test, Mankai (grown by Hinoman Ltd., Israel) will be provided as a fresh, whole, product. Methods: 36 men will be randomized to consume the following food items, which will be equivalent to 30gr protein, after 12h night fasting: 1. Reference group: animal protein food source: White cheese, intact, plus 250ml mineral water 2. Test group 1: plant food source: Green peas, intact, cooked, plus 250ml mineral water 3. Test group 2: plant food source: Wolffia globosa (Mankai), intact, cooked, plus 250ml mineral water The participants will be asked to maintain a stable diet (according to guidelines that will be provided) for 3 days prior to the test meal. Blood samples will be taken at times 0, 30, 90, and 180 minutes.


Recruitment information / eligibility

Status Completed
Enrollment 36
Est. completion date July 2017
Est. primary completion date February 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 30 Years and older
Eligibility Inclusion Criteria: - age >30 years; abdominal adiposity (waist circumference: men > 102 cm, women > 88 cm) or dyslipidemia Exclusion Criteria: - triglycerides>400 mg/dL; serum creatinine>2 mg/dL; - disturbed liver function; - pregnant or lactating women; - presence of active cancer, is receiving or received chemotherapy in the last three years; participation in another trial; - participants who are treated with Coumadin (warfarin)

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
White cheese
animal protein food source: White cheese (contains 30g protein), intact, plus 250ml mineral water
Green peas
Green peas (contains 30g protein), intact, cooked, plus 250ml mineral water
Mankai
Wolffia globosa (Mankai, contains 30g protein), intact, cooked, plus 250ml mineral water

Locations

Country Name City State
Israel nuclear research center Negev Dimona

Sponsors (3)

Lead Sponsor Collaborator
Ben-Gurion University of the Negev Harvard School of Public Health (HSPH), University of Leipzig

Country where clinical trial is conducted

Israel, 

Outcome

Type Measure Description Time frame Safety issue
Primary Amino Acid Profile (Blood Biomarkers) will be analysed by metabolomic for amino acid profile (trajectory) 3 hours
Secondary Glycemic Profile glucose (blood biomarkers) 3 hours
Secondary Lipid Profile HDL cholesterol fractions (blood biomarkers) 3 hours
Secondary Liver Function ALT (blood biomarkers) 3 hours
Secondary Minerals potassium (blood measures) 3 hours
Secondary Vitamins B12 (blood measures) 3 hours
Secondary Glycemic Profile-Insulin Insulin (blood biomarker) 3 hours
Secondary Triglycerides Triglycerides levels- Lipid profile 3 hours
Secondary Liver Enzymes- ASAT ASAT - Liver enzymes 3 hours
Secondary Magnesium Magnesium levels 3 hours